Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.（PSTX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PSTX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
2
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Poseida Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
PSTX 季度内部人买卖趋势
PSTX 内幕交易卖出 · PSTX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
PSTX 高管卖出股份 · PSTX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jan 8, 2025 | Amado Rafael Director | Other | 58,950 | $531K | Form 4 |
| Jan 8, 2025 | Corning Luke Director | Other | 58,950 | $531K | Form 4 |
| Jan 8, 2025 | Schmid John P. Director | Other | 58,950 | $531K | Form 4 |
| Jan 8, 2025 | Lloyd Marcea Bland Director | Other | 68,950 | $621K | Form 4 |
| Jan 8, 2025 | Collins Cynthia Director | Other | 58,950 | $531K | Form 4 |
| Jan 8, 2025 | BAUM CHARLES M Director | Other | 78,600 | $707K | Form 4 |
| Jan 8, 2025 | Mylet Johanna CFO | Other | 254,852 | $2.29M⚡ | Form 4 |
| Jan 8, 2025 | Rizvi Syed Ali-aamir Chief Medical Officer | Other | 185,000 | $1.67M⚡ | Form 4 |
| Jan 8, 2025 | LEONHARDT HARRY J GC & Chief Compliance Officer | Other | 223,640 | $2.01M⚡ | Form 4 |
| Jan 8, 2025 | Gergen Mark J President and CEO · Director | Other | 636,726 | $5.73M⚡ | Form 4 |
| Jan 8, 2025 | Yarema Kristin President and CEO | Other | 615,836 | $5.54M⚡ | Form 4 |
| Jan 2, 2025 | Gergen Mark J Executive Chairman · Director | Other | 23,313 | $224K | Form 4 |
| Dec 10, 2024 | Gergen Mark J Executive Chairman · Director | Option | 30,000 | $83K | Form 4 |
| Dec 10, 2024 | Gergen Mark J Executive Chairman · Director | Sale | 30,000 | $284K | Form 4 |
| Nov 26, 2024 | Gergen Mark J Executive Chairman · Director | Option | 30,000 | $83K | Form 4 |
| Nov 26, 2024 | Gergen Mark J Executive Chairman · Director | Sale | 30,000 | $278K | Form 4 |
| Jun 17, 2024 | Schmid John P. Director | Award | 19,650 | — | Form 4 |
| Jun 17, 2024 | Lloyd Marcea Bland Director | Award | 19,650 | — | Form 4 |
| Jun 17, 2024 | Corning Luke Director | Award | 19,650 | — | Form 4 |
| Jun 17, 2024 | Collins Cynthia Director | Award | 19,650 | — | Form 4 |
| Jun 17, 2024 | BAUM CHARLES M Director | Award | 19,650 | — | Form 4 |
| Jun 17, 2024 | Amado Rafael Director | Award | 19,650 | — | Form 4 |
| Apr 1, 2024 | Rizvi Syed Ali-aamir Chief Medical Officer | Award | 185,000 | — | Form 4 |
| Mar 1, 2024 | Mylet Johanna CFO | Award | 80,743 | — | Form 4 |
| Mar 1, 2024 | Mylet Johanna CFO | Other | 18,091 | $75K | Form 4 |
Rizvi Syed Ali-aamir
Chief Medical Officer
日期
Jan 8
股数
185,000
均价
$9.00
总金额
$1.67M ⚡
LEONHARDT HARRY J
GC & Chief Compliance Officer
日期
Jan 8
股数
223,640
均价
$9.00
总金额
$2.01M ⚡
Gergen Mark J
President and CEO · Director
日期
Jan 8
股数
636,726
均价
$9.00
总金额
$5.73M ⚡
Gergen Mark J
Executive Chairman · Director
日期
Dec 10
股数
30,000
均价
$2.78
总金额
$83K
Gergen Mark J
Executive Chairman · Director
日期
Nov 26
股数
30,000
均价
$2.78
总金额
$83K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PSTX 内幕交易
PSTX 内幕交易
Poseida Therapeutics, Inc.（PSTX）内幕交易数据来源于公司内部人（包括PSTX）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。PSTX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Poseida Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PSTX 内幕交易 · 5个问题Poseida Therapeutics, Inc.（PSTX）的内部人包括高管和董事，如PSTX等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026